Ovid Therapeutics (OVID) Interest & Investment Income (2018 - 2020)

Ovid Therapeutics (OVID) has reported Interest & Investment Income for 3 consecutive years, with -$65704.0 the latest figure, recorded in Q2 2020.

• For the quarter ending Q2 2020, Interest & Investment Income fell 4766.96% year-over-year to -$65704.0; the trailing twelve-month figure through Mar 2020 stood at $64354.0 (up 72.7% YoY), and the FY2019 full-year result was $4298.0, up 334.99% from the prior year.
• Interest & Investment Income fell to -$65704.0 in Q2 2020 per OVID's latest filing, from $63235.0 in the prior quarter.
• Across five years, Interest & Investment Income topped out at $63235.0 in Q1 2020 and bottomed at -$65704.0 in Q2 2020.
• Historically, Interest & Investment Income has averaged $0.0 across 3 years, with a median of $2846.0 in 2018.
• The widest YoY moves for Interest & Investment Income: up 1889.15% in 2020, down 4766.96% in 2020.
• Over 3 years, Interest & Investment Income stood at $2846.0 in 2018, then fell by 13.25% to $2469.0 in 2019, then tumbled by 2761.16% to -$65704.0 in 2020.
• According to Business Quant data, Interest & Investment Income over the past three periods registered -$65704.0, $63235.0, and $2469.0 for Q2 2020, Q1 2020, and Q4 2019 respectively.